Amount$80M
SeriesSeries B
AnnouncedJul 17, 2024
Time since last round265 mo
SectorHealthcare, Drug Discovery, Clinical Development, Biomarkers, Target Discovery, Combination Selection, Indication Expansion, Drug Development, Pharmaceuticals, Biotech
Sub-sectorMachine Learning, Natural Language Processing, Artificial Intelligence
Strong
A strong, well-structured round.
Round size vs peers
Larger than the typical Series B round (2.9×).
Syndicate size
Healthy syndicate of 5 investors.
Insider conviction
2 existing investors re-upped — insiders doubling down.
Investor track record
A mix of established and emerging investors.
Heuristic read of round size vs peers, syndicate size, insider conviction, and investor track record. Not investment advice.
vs. Series B rounds (996)
Round size distribution83th pct
smaller Series B roundslarger
vs. Healthcare, Drug Discovery, Clinical Development, Biomarkers, Target Discovery, Combination Selection, Indication Expansion, Drug Development, Pharmaceuticals, Biotech (5)
Round size in sector100th pct
$4Mthis round: $80M$20M
